首页> 外文期刊>Biomaterials >The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles
【24h】

The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles

机译:非共价相互作用在高分子胶束的抗癌药物负载和动力学稳定性中的作用

获取原文
获取原文并翻译 | 示例
       

摘要

A new series of acid- and urea-functionalized polycarbonate block copolymers were synthesized via organocatalytic living ring-opening polymerization using methoxy poly(ethylene glycol) (PEG) as a macroinitiator to form micelles as drug delivery carriers. The micelles were characterized for critical micelle concentration, particle size and size distribution, kinetic stability and loading capacity for a model anticancer drug, doxorubicin (DOX) having an amine group. The acid/urea groups were placed in block forms (i.e. acid as the middle block or the end block) or randomly distributed in the polycarbonate block to investigate molecular structure effect. The micelles formed from the polymers in both random and block forms provided high drug loading capacity due to strong ionic interaction between the acid in the polymer and the amine in DOX. However, the polymers with acid and urea groups placed in the block forms formed micelles with wider size distribution (two size populations), and their DOX-loaded micelles were less stable. The number of acid/urea groups in the random form was further varied from 5 to 8, 13 and 19 to study its effects on self-assembly behaviors and DOX loading. An increased number of acid/urea groups yielded DOX-loaded micelles with smaller size and enhanced kinetic stability because of improved inter-molecular polycarbonate-polycarbonate (urea-urea and urea-acid) hydrogen-bonding and polycarbonate-DOX (acid-amine) ionic interactions. However, when the number of acid/urea groups was 13 or higher, micelles aggregated in a serum-containing medium, and freeze-dried DOX-loaded micelles were unable to re-disperse in an aqueous solution. Among all the polymers synthesized in this study, 1b with 8 acid/urea groups in the random form had the optimum properties. Invitro release studies showed that DOX release from 1b micelles was sustained over 7h without significant initial burst release. MTT assays demonstrated that the polymer was not toxic towards HepG2 and HEK293 cells. Importantly, DOX-loaded micelles were potent against HepG2 cells with IC 50 of 0.26mg/L, comparable to that of free DOX (IC 50: 0.20mg/L). In addition, DOX-loaded 1b micelles yielded lower DOX content in the heart tissue of the tested mice as compared to free DOX formulation after i.v. injection. These findings signify that 1b micelles may be a promising carrier for delivery of anticancer drugs that contain amine groups.
机译:通过使用甲氧基聚乙二醇(PEG)作为大分子引发剂的有机催化活性开环聚合反应,合成了一系列新的酸和脲官能化的聚碳酸酯嵌段共聚物,以形成胶束作为药物传递载体。表征了胶束的临界胶束浓度,粒径和尺寸分布,动力学稳定性和对具有胺基的模型抗癌药阿霉素(DOX)的负载能力。将酸/脲基团以嵌段形式(即,酸作为中间嵌段或末端嵌段)放置或随机分布在聚碳酸酯嵌段中以研究分子结构效应。由于聚合物中的酸与DOX中的胺之间存在强烈的离子相互作用,因此由聚合物以无规和嵌段形式形成的胶束具有很高的载药量。然而,具有酸和脲基团的聚合物以嵌段形式形成的胶束具有较宽的尺寸分布(两个尺寸的种群),并且其DOX负载胶束的稳定性较差。随机形式的酸/脲基团的数量进一步从5变为8、13和19,以研究其对自组装行为和DOX负载的影响。由于改善了分子间聚碳酸酯-聚碳酸酯(脲-尿素和尿酸)氢键键合和聚碳酸酯-DOX(酸-胺)的结合,增加了酸/脲基团的数量,从而制得了具有较小尺寸和增强动力学稳定性的DOX负载胶束。离子相互作用。然而,当酸/脲基团的数目为13或更高时,胶束聚集在含血清的培养基中,并且冷冻干燥的装载有DOX的胶束不能再分散在水溶液中。在这项研究中合成的所有聚合物中,具有8个酸/脲基的无规形式的1b具有最佳性能。体外释放研究表明,从1b胶束释放的DOX持续7h以上没有明显的初始爆发释放。 MTT分析表明该聚合物对HepG2和HEK293细胞无毒。重要的是,负载DOX的胶束对HepG2细胞有效,IC 50为0.26mg / L,与游离DOX相当(IC 50:0.20mg / L)。另外,与静脉内注射后的游离DOX制剂相比,装载DOX的1b胶束在被测小鼠的心脏组织中产生较低的DOX含量。注射。这些发现表明1b胶束可能是有希望的载体,用于递送含有胺基的抗癌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号